Pharmaceuticals
AstraZeneca Seroquel XR Generic Delay Antitrust Class Action
A number of antitrust class actions in recent years have centered on covert agreements between a company with a popular and lucrative drug and one or more other companies who may wish to put out a generic version. In this antitrust class action, the complaint claims that AstraZeneca companies entered into agreements with Handa Pharmaceuticals, Read more
CVS Makes Opioid Buyers Get Overdose Drug California Class Action
Can a pharmacy force you to purchase a drug you don’t want in order to allow you to purchase one that you have a prescription for? The complaint alleges that CVS Pharmacy, Inc. and CVS Health Corporation are forcing customers who want a prescription for an opioid-containing drug filled to also purchase prescribed medication Naloxone Read more
Suboxone Antitrust Settlement
Reckitt Benckiser Group plc is settling a Federal Trade Commission (FTC) antitrust action against it for $60 million. Suboxone is used to treat opioid addiction. The complaint alleged that the company tried to retain its market and thwart the makers of generics in order to keep its monopoly. According to the complaint, it tried to Read more
Opioid Makers, Distributors Sued for Problems with Newborns Class Action
The plaintiffs in this case are two babies, Baby AM and Baby RH, who were born dependent on opioids. The complaint says, “The first days of Baby Plaintiffs’ lives were spent in excruciating pain as doctors weaned the infants from opioid addiction.” This class action brings suit against a long list of pharmaceutical makers, and Read more
Thalomid and Revlimid Antitrust Settlement
Celgene is settling, for the second time, an antitrust class action alleging that it took action to prevent or delay the entry of cheaper generics to the market. The complaint alleged that consumers and third-party payors were forced to pay higher prices for than they would have had generics been available. Celgene was able to Read more
Drug Companies and Baby Addiction Florida Class Action
The plaintiffs in this class action are babies born dependent on opioids, and their mothers. The complaint offers a very long list of defendant companies, including distributors, manufacturers, and marketers. (See the complaint linked below for the full list of companies.) It says, “Baby Plaintiffs and their mothers are victims of the opioid crisis that Read more
Pfizer, Ranbaxy Lipitor Generic Anticompetitive Agreement Class Action
With the high prices of US drugs, a popular medicine can be an enormous moneymaker for a pharmaceutical company. But the patents that give those companies exclusivity have a limited term, after which generics or bioequivalents can come on the market, driving prices downwards. The complaint for this antitrust class action alleges that a number Read more
Premarin, Prempro, Premphase California Settlement
Wyeth, Inc. and Wyeth Pharmaceuticals, Inc. is settling a class action against it with a $200 million payment. The complaint alleged that Wyeth violated California laws by making false or misleading representations about the drugs Premarin, Prempro, and Premphase, including (a) that the medications lowered cardiovascular, Alzheimer’s, and dementia risks, and (b) that the medications Read more
Analog Insulin Drug Makers’ Kickbacks to PBMs RICO Class Action
This class action alleges that pharmacy benefit managers (PBMs) are taking kickbacks from drug manufacturers in ways that raise the prices of prescription drugs. The drugs at issue in this case are analog insulin drugs, and the case has been brought by a drug wholesaler, which claims that it must pay more for drugs because Read more
Loestrin 24 Fe, Minastrin 24 Fe Antitrust Settlement
This antitrust case has a long list of defendants, including companies related to Lupin, Warner Chilcott, and Watson. The complaint was filed by a group of end-payors who claimed that the companies violated antitrust laws and engaged in anticompetitive behavior by conspiring to keep generic versions of Loestrin 24 Fe and Minastrin 24 Fe off Read more